tomeko

Epidermolysis bullosa simplex 1A, generalized severe

Just diagnosed with Epidermolysis bullosa simplex 1A, generalized severe?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Epidermolysis bullosa simplex 1A, generalized severe, look for clinical trials, and connect with others living with it — all in one place.

Open the full Epidermolysis bullosa simplex 1A, generalized severe hub →

Overview

Epidermolysis bullosa simplex 1A, generalized severe is a rare condition. Also known as Autosomal dominant generalized EBS, severe form, Epidermolysis bullosa simplex herpetiformis, Epidermolysis bullosa simplex, Dowling-Meara type. Tomeko brings together the specialists, research, clinical trials, treatments and community for Epidermolysis bullosa simplex 1A, generalized severe so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:79396 · OMIM 131760, 619555 · ICD-10 Q81.0 · GARD 0002141

Find care for Epidermolysis bullosa simplex 1A, generalized severe

Authoritative references for Epidermolysis bullosa simplex 1A, generalized severe

Common questions

I was just diagnosed with Epidermolysis bullosa simplex 1A, generalized severe — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Epidermolysis bullosa simplex 1A, generalized severe, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Epidermolysis bullosa simplex 1A, generalized severe?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Epidermolysis bullosa simplex 1A, generalized severe, filtered to your area.

Are there clinical trials for Epidermolysis bullosa simplex 1A, generalized severe?

Tomeko shows live, recruiting studies for Epidermolysis bullosa simplex 1A, generalized severe from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com